The company reported $9 million in gross profits for the first half of the year, up 122 percent from last year. Mazor’s net loss this quarter increased from $1.1 million last year to $4.4 million, due to an increase in financing income.
The increased profits are due to an increase in Renaissance robotic spine system globally. Currently, 54 systems are installed, and the company received its first follow-up order from a U.S. hospital corporation during the second quarter.
More Articles on Supply Chain:
12 Spine Devices Receive FDA 510(k) Clearance in July
Bacterin International Names Daniel Goldberger CEO
Stryker Launches 2 Minimally Invasive Spine Devices for Facet Joint Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
